| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,424 |
3,444 |
$160K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,390 |
1,489 |
$62K |
| 99215 |
Prolong outpt/office vis |
413 |
293 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
427 |
285 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
593 |
461 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
224 |
185 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
252 |
191 |
$1K |
| 90756 |
|
90 |
70 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
75 |
69 |
$637.86 |
| 93000 |
|
64 |
63 |
$515.96 |
| 87428 |
|
36 |
30 |
$462.96 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
67 |
57 |
$186.45 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
27 |
26 |
$159.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
81 |
71 |
$108.98 |
| 81002 |
|
68 |
53 |
$72.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$56.87 |
| 82947 |
|
24 |
20 |
$56.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$13.53 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
144 |
118 |
$1.15 |
| 3079F |
|
144 |
121 |
$0.00 |
| 3075F |
|
44 |
38 |
$0.00 |
| 3074F |
|
177 |
143 |
$0.00 |
| 3080F |
|
73 |
52 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
18 |
13 |
$0.00 |
| 3077F |
|
113 |
83 |
$0.00 |
| 3078F |
|
99 |
77 |
$0.00 |
| 1159F |
|
70 |
60 |
$0.00 |
| 1160F |
|
35 |
17 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$0.00 |